A Study in Healthy Men to Test How BI 1839100 is Taken up and Handled by the Body

NCT06572111 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

8

Enrollment

INDUSTRY

Sponsor class

Stopped Company decision

Conditions

Healthy

Interventions

DRUG: BI 1839100 (C-14) formulation 1
DRUG: BI 1839100
DRUG: BI 1839100 (C-14) formulation 2

Sponsor

Boehringer Ingelheim